advs {pharmaverseadam}R Documentation

Vital Signs Analysis

Description

An example of ADVS ADaM dataset

Usage

advs

Format

A data frame with 101 columns:

STUDYID

Study Identifier

DOMAIN

Domain Abbreviation

USUBJID

Unique Subject Identifier

VSSEQ

Sequence Number

VSTESTCD

Vital Signs Test Short Name

VSTEST

Vital Signs Test Name

VSPOS

Vital Signs Position of Subject

VSORRES

Result or Finding in Original Units

VSORRESU

Original Units

VSSTRESC

Character Result/Finding in Std Format

VSSTRESN

Numeric Result/Finding in Standard Units

VSSTRESU

Standard Units

VSSTAT

Completion Status

VSLOC

Location of Vital Signs Measurement

VSBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

VSDTC

Date/Time of Measurements

VSDY

Study Day of Vital Signs

VSTPT

Planned Time Point Name

VSTPTNUM

Planned Time Point Number

VSELTM

Planned Elapsed Time from Time Point Ref

VSTPTREF

Time Point Reference

TRTSDT

Date of First Exposure to Treatment

TRTEDT

Date of Last Exposure to Treatment

TRT01A

Actual Treatment for Period 01

TRT01P

Planned Treatment for Period 01

ADT

Analysis Date

ADY

Analysis Relative Day

PARAMCD

Parameter Code

AVAL

Analysis Value

ATPTN

Analysis Timepoint (N)

ATPT

Analysis Timepoint

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

DTYPE

Derivation Type

ONTRTFL

On Treatment Record Flag

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

A1LO

Analysis Range 1 Lower Limit

A1HI

Analysis Range 1 Upper Limit

ANRIND

Analysis Reference Range Indicator

BASETYPE

Baseline Type

ABLFL

Baseline Record Flag

BASE

Baseline Value

BNRIND

Baseline Reference Range Indicator

CHG

Change from Baseline

PCHG

Percent Change from Baseline

ANL01FL

Analysis Flag 01

TRTP

Planned Treatment

TRTA

Actual Treatment

ASEQ

Analysis Sequence Number

AVALCA1N

Analysis Value Category 1 (N)

AVALCAT1

Analysis Value Category 1

PARAM

Parameter

PARAMN

Parameter (N)

SUBJID

Subject Identifier for the Study

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFICDTC

Date/Time of Informed Consent

RFPENDTC

Date/Time of End of Participation

DTHDTC

Date/Time of Death

DTHFL

Subject Death Flag

SITEID

Study Site Identifier

AGE

Age

AGEU

Age Units

SEX

Sex

RACE

Race

ETHNIC

Ethnicity

ARMCD

Planned Arm Code

ARM

Description of Planned Arm

ACTARMCD

Actual Arm Code

ACTARM

Description of Actual Arm

COUNTRY

Country

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

TRTDURD

Total Treatment Duration (Days)

SCRFDT

Screen Failure Date

EOSDT

End of Study Date

EOSSTT

End of Study Status

FRVDT

Final Retrievel Visit Date

RANDDT

Date of Randomization

DTHDT

Date of Death

DTHADY

Relative Day of Death

LDDTHELD

Elapsed Days from Last Dose to Death

LSTALVDT

Date Last Known Alive

AGEGR1

Pooled Age Group 1

SAFFL

Safety Population Flag

RACEGR1

Pooled Race Group 1

REGION1

Geographic Region 1

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHB30FL

Death Within 30 Days of First Trt Flag

Source

Generated from admiral package (template ad_advs.R).

References

None

Examples

data("advs")

[Package pharmaverseadam version 1.0.0 Index]